INHALED ANTIBIOTICS MARKET ANALYSIS

Market Challenges And Opportunities

Global Inhaled Antibiotics Market– Driver

Rising incidence of respiratory diseases such as asthma, chronic obstructive pulmonary diseases (COPD), and bronchitis

Rising incidence of respiratory diseases such as asthma, chronic obstructive pulmonary diseases (COPD), and bronchitis is expected to drive the market growth over the forecast period. For instance, according to the World Health Organization, report in May 2020, asthma is the most common chronic disease among children worldwide and around 339 million people were living with asthma in 2016. Similarly, according to the same source, over 80% of asthma-related deaths occur in low-and lower-middle income countries.

Global Inhaled Antibiotics Market: Restraint

Side effects associated with drug inhalation and unattainability of single effective inhaler device

Side effects associated with drug inhalation and unattainability of single effective inhaler device, which is expected to hinder growth of the market. Side-effects related to inhaled antibiotics such as nephrotoxicity, neurotoxicity, dyspnea and many others may hamper the inhaled antibiotics market growth. According to an article published in the National Library of Medicine in October 2021, reported therapy with aerosolized antibiotics often causes local side effects including mild respiratory symptoms, although the occurrence of serious side effects such as bronchospasm, nephrotoxicity, neurotoxicity and dyspnea.